Mayo Clinic Study Reveals How Genetic Testing Is Rewriting Pulmonary Fibrosis Care Protocols
Integration of telomere length analysis and genetic sequencing into routine practice is changing diagnoses and treatment decisions for lung disease patients
India Launches Unified Drug Database to Power Next-Generation Healthcare AI
New national registry standardizes pharmaceutical data across the world's most populous nation, creating infrastructure for AI-driven clinical tools and medication safety systems.
RNA-Targeting Breakthrough: Ionis Scores Dual Wins with First-Ever FCS Therapy and $430M Licensing Deal
FDA approval of Tryngolza for ultra-rare pancreatitis disorder and major partnership for hereditary angioedema treatment signal growing confidence in antisense oligonucleotide technology.
Mountain Towns Band Together to Crack the Code on Rural Mental Health Crisis
Pooling mental health data across twelve isolated mountain communities reveals hidden behavioral health crises driven by seasonal work instability and geographic isolation.
Why the FDA Is Betting on Biology-Driven AI to Fix Drug Development's $2 Billion Failure Problem
Mechanistic AI that explains *why* drugs work—rather than just predicting outcomes—could finally give regulators the transparency needed to accelerate drug development and reduce catastrophic trial failures.
Veterans Health Data Reveals Unexpected Heart Protection from Updated COVID Boosters
Analysis of 2.3 million veterans reveals the updated vaccine formulation may offer unexpected cardiovascular protection alongside infection prevention benefits.
Why Your Hospital's AI Dreams May Be Failing Before They Start: The Infrastructure Gap No One Talks About
Most hospital AI projects fail not because the technology is flawed, but because foundational data infrastructure wasn't built first.
Inside Interoception: The hidden sense of how you feel inside
This internal sensing system continuously monitors heart rate, breathing, and metabolic states—and disruptions may explain why patients feel anxious or unwell without obvious cause.
Nvidia, Abridge collaborate to develop healthcare-specific AI model
The partnership aims to create a purpose-built foundation model for clinical conversations, moving beyond adapted general-purpose AI to address unique medical communication challenges.
FDA Approves Australian Blowfly Larvae to Devour Dead Tissue in Chronic Wounds
FDA clears first medical maggot product using Australian sheep blowfly larvae, breaking the single-species monopoly in biological wound debridement therapy.
OpenEvidence Launches Voice Mode and Closes $250M Series D at $12 Billion Valuation
OpenEvidence has launched a hands-free Voice Mode for its AI-powered medical search platform and disclosed a $250 million Series D round at a $12 billion valuation, backed by Google Ventures, Nvidia, Thrive Capital, and Mayo Clinic.
KFF Report Warns AI Could Exacerbate Racial Health Disparities Without Targeted Intervention
A new report from KFF (Kaiser Family Foundation) finds that AI systems deployed in clinical settings could widen existing racial and ethnic health disparities if not designed, validated, and monitored with equity as an explicit objective.